Search Results 121-130 of 19407 for lupus

  1. Medical Research & Education - Mayo Clinic News Network

    A recent Mayo Clinic study highlights the link between glucocorticoid dosage and outcomes in patients with lupus nephritis, a type of kidney inflammation caused ...

  2. Overview - Rheumatology - Mayo Clinic Research

    Systemic autoimmune diseases — systemic lupus erythematosus, scleroderma, myositis and related disorders. Inflammatory arthritis — rheumatoid arthritis ...

  3. Glomerulonephritis - Symptoms and causes - Mayo Clinic

    Infections · Post-streptococcal glomerulonephritis. ; Autoimmune diseases · Lupus. ; Vasculitis · Polyarteritis. ; Sclerotic conditions · High blood pressure. ; Other ...

  4. Medical Research & Education - Mayo Clinic News Network

    Starting from the beginning may lead to better outcomes for lupus featured image. Health & Wellness. Starting from the beginning may lead to better outcomes ...

  5. Medical Research & Education - Mayo Clinic News Network

    Starting from the beginning may lead to better outcomes for lupus featured image. Health & Wellness. Starting from the beginning may lead to better outcomes ...

  6. Kidney Transplant Program - Conditions treated - Mayo Clinic

    High blood pressure (hypertension) · HIV/AIDS · Kidney infection · Kidney stones · Lupus · Multiple myeloma · Polycystic kidney disease · Scleroderma ...

  7. Vikas Majithia, M.B.B.S., M.P.H. - Doctors and Medical Staff - Mayo Clinic

    ... Lupus Study (PALS), PICORI funded — RAPROPR study to evaluate the outcomes in RA patients between various non-TNFi biologics and establishment of a lupus ...

  8. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

    A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis ... lupus nephritis (LN) when ...

  9. A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER) - Mayo Clinic

    A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER).

  10. Repeated Episodes of Coronary Artery Spasm Can Lead to Deterioration of Heart Function

    Additional risk factors for coronary artery spasm are many and include exposure to cold, certain autoimmune diseases such as lupus, migraine, and extreme ...